StockData

KALA BIO, Inc. (KALA) stock

KALANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 5/30
$3.43−0.40 (-10.44%)

Close on Nov 17, 2026Market cap $66.34MP/E –Yield –

Kala Bio cash

Cash and short-term investments held at the end of each period.

Kala Bio's cash was $7.23M at Jun 30, 2026. For fiscal 2025 it was $7.56M, down 85.2% from the year before. Over ten years it grew 2.8% a year on average. The highest annual figure on record is $170.90M in fiscal 2018.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.56M-85.2%
FY2024Dec 31, 2024$51.18M+0.6%
FY2023Dec 31, 2023$50.90M-27.8%
FY2022Dec 31, 2022$70.50M-23.5%
FY2021Dec 31, 2021$92.14M-40.0%
FY2020Dec 31, 2020$153.54M–
FY2019Dec 31, 2019$0-100.0%
FY2018Dec 31, 2018$170.90M+49.0%
FY2017Dec 31, 2017$114.70M+151.6%
FY2016Dec 31, 2016$45.58M+691.5%
FY2015Dec 31, 2015$5.76M-46.3%
FY2014Dec 31, 2014$10.73M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$7.23M-77.4%
Q1 FY2026Mar 31, 2026$8.76M-79.2%
Q4 FY2025Dec 31, 2025$7.56M-85.2%
Q3 FY2025Sep 30, 2025$21.10M-57.1%
Q2 FY2025Jun 30, 2025$31.94M-41.1%
Q1 FY2025Mar 31, 2025$42.22M-12.9%
Q4 FY2024Dec 31, 2024$51.18M+0.6%
Q3 FY2024Sep 30, 2024$49.20M-12.2%
Q2 FY2024Jun 30, 2024$54.20M-8.4%
Q1 FY2024Mar 31, 2024$48.48M-23.8%
Q4 FY2023Dec 31, 2023$50.90M-27.8%
Q3 FY2023Sep 30, 2023$56.06M+7.0%
Q2 FY2023Jun 30, 2023$59.18M+32.8%
Q1 FY2023Mar 31, 2023$63.64M-9.3%
Q4 FY2022Dec 31, 2022$70.50M-23.5%
Q3 FY2022Sep 30, 2022$52.39M-57.9%
Q2 FY2022Jun 30, 2022$44.57M-70.2%
Q1 FY2022Mar 31, 2022$70.16M-55.0%
Q4 FY2021Dec 31, 2021$92.14M-40.0%
Q3 FY2021Sep 30, 2021$124.50M-21.8%
Q2 FY2021Jun 30, 2021$149.64M-18.9%
Q1 FY2021Mar 31, 2021$155.99M-20.6%
Q4 FY2020Dec 31, 2020$153.54M–
Q3 FY2020Sep 30, 2020$159.12M+63.1%
Q2 FY2020Jun 30, 2020$184.56M+56.4%
Q1 FY2020Mar 31, 2020$196.46M+41.4%
Q4 FY2019Dec 31, 2019$0-100.0%
Q3 FY2019Sep 30, 2019$97.56M+30.2%
Q2 FY2019Jun 30, 2019$118.01M+29.4%
Q1 FY2019Mar 31, 2019$138.94M+38.2%
Q4 FY2018Dec 31, 2018$170.90M+49.0%
Q3 FY2018Sep 30, 2018$74.91M-38.6%
Q2 FY2018Jun 30, 2018$91.21M+246.1%
Q1 FY2018Mar 31, 2018$100.53M+179.1%
Q4 FY2017Dec 31, 2017$114.70M+151.6%
Q3 FY2017Sep 30, 2017$122.05M+135.3%
Q2 FY2017Jun 30, 2017$26.35M–
Q1 FY2017Mar 31, 2017$36.02M–
Q4 FY2016Dec 31, 2016$45.58M–
Q3 FY2016Sep 30, 2016$51.88M–

More Kala Bio figures

See a number that looks wrong?